Omniscient Neurotechnology
PrivateLast Round
Series D
May 29, 2026
Est. Valuation
$295M
Total Funding Raised
$94.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Omniscient Neurotechnology operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Series D round in May 2026.
Omniscient Neurotechnology is a healthcare technology company that offers a cloud-based connectomic analysis platform utilizing artificial intelligence to transform standard MRI scans into detailed brain network maps, facilitating the identification of neurological connections for improved patient care and predictive analytics.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Data Visualization
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniscient Neurotechnology Comparables
Compare Omniscient Neurotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainSightAI | 82% | |
| Sora Neuroscience | 80% | |
| Synaptive Medical | 78% |
For institutional investors. Book with your work email.
Omniscient Neurotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 29, 2026 | ||||
| Pre Seed | Apr 3, 2026 | ||||
| Series C | Jun 11, 2024 | ||||
| Series B | Jul 19, 2021 | ||||
| Seed | Jan 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Omniscient Neurotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MS&AD Ventures | Pre Seed |
| Anamcara Capital | Pre Seed |
| Plug and Play Tech Center | Pre Seed |
| Drysdale Ventures | Pre Seed |
| xdeck | Pre Seed |
| National Reconstruction Fund Corporation | Series D |
| OIF Ventures | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2026
$13.3M round completed.
- Apr 15, 2026
Neurological planning and visualization tool using resting-state fMRI has received FDA clearance.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 11, 2026
Omniscient Neurotechnology Pty. launches Quicktome Deep Brain, a new Quicktome workflow that brings connectomic analysis to deep brain stimulation, after receiving 510(k) clearance from the U.S. Food and Drug Administration in Australia on Sep 11th '26.
For institutional investors. Book with your work email.
Omniscient Neurotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omniscient Neurotechnology's valuation, stock price, and market status.
Is Omniscient Neurotechnology a public or private company?
Omniscient Neurotechnology is a private company.
What is the current stock price of Omniscient Neurotechnology?
Omniscient Neurotechnology is a private company, so its shares have no public market price. Caplight tracks Omniscient Neurotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omniscient Neurotechnology worth (valuation)?
Omniscient Neurotechnology's valuation is estimated at $295.0M based on funding round data.
Can I buy Omniscient Neurotechnology stock?
Omniscient Neurotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omniscient Neurotechnology's last funding round?
Omniscient Neurotechnology's most recent funding round was Series D on May 29, 2026.
Who are the main investors in Omniscient Neurotechnology?
Key investors in Omniscient Neurotechnology include National Reconstruction Fund Corporation, OIF Ventures, Seedcamp.
Will Omniscient Neurotechnology IPO soon?
No public IPO plans have been announced for Omniscient Neurotechnology.
How can I track Omniscient Neurotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Omniscient Neurotechnology's shares on secondary markets.